{"denoms":[{"counts":[{"groupId":"BG000","value":"62"}],"units":"Participants"}],"groups":[{"description":"Bevacizumab 15 mg/kg IV, every 3 weeks (one cycle) until disease progression or adverse effects prohibit further therapy","id":"BG000","title":"Bevacizumab"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.5","value":"55.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"10-19 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"20-29 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"30-39 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"40-49 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}]}],"title":"50-59 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"60-69 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"70-79 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Adenocarcinoma, Unspecified"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Clear Cell Carcinoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Endometrioid Adenocarcinoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Mixed Epithelial Carcinoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"51"}]}],"title":"Serous Adenocarcinoma"}],"paramType":"NUMBER","title":"Histologic Type","unitOfMeasure":"participants"}],"populationDescription":"Eligible and treated patients."}